Regeneron Pharmaceuticals, Inc.
REGNNASDAQHealthcare● Active
$611.34
$-24.11(-3.79%)
Market Cap$63.0B
P/E Ratio—
52W High$821.11
52W Low$503.25
Regeneron Pharmaceuticals, Inc. (REGN) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · REGN · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $8.61B | $9.01B | $10.84B | $7.74B | $5.69B |
| Net Receivables | $5.74B | $6.21B | $5.67B | $5.33B | $6.04B |
| Inventory | $3.20B | $3.09B | $2.58B | $2.40B | $1.95B |
| Total Current Assets | $18.02B | $18.66B | $19.48B | $15.88B | $14.01B |
| PP&E Net | $5.12B | $4.60B | $4.15B | $3.76B | $3.48B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $1.26B | $1.15B | $1.04B | $0.92B | $0.01B |
| Total Assets | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.94B | $0.79B | $0.61B | $0.59B | $0.56B |
| Total Current Liabilities | $4.37B | $3.94B | $3.42B | $3.14B | $3.93B |
| Long-Term Debt | $1.99B | $1.98B | $1.98B | $1.98B | $1.98B |
| Total Liabilities | $9.30B | $8.41B | $7.11B | $6.55B | $6.67B |
| Stockholders Equity | |||||
| Retained Earnings | $35.80B | $31.67B | $27.26B | $23.31B | $18.97B |
| Total Stockholders Equity | $31.26B | $29.35B | $25.97B | $22.66B | $18.77B |
| Total Liab & Equity(computed) | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B |
| Debt Summary | |||||
| Total Debt | $2.71B | $2.70B | $2.70B | $2.70B | $2.70B |
| Net Debt | ($0.41B) | $0.22B | ($0.03B) | ($0.40B) | ($0.19B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Regeneron Pharmaceuticals, Inc. data
About Regeneron Pharmaceuticals, Inc. (REGN) Balance Sheet
Regeneron Pharmaceuticals, Inc. (REGN) balance sheet shows total assets of $40.56B with cash of $8.61B. Total liabilities are $9.30B, total debt $2.71B, and stockholders equity $31.26B.
Frequently asked questions
REGN · 4 questionsRegeneron Pharmaceuticals, Inc. has total debt of $2.71B with net debt of ($0.41B).
REGN total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10